Corium

Recent Finacing

Debt

Recent Raise

$235M

Corium is a commercial-stage biopharmaceutical company developing and commercializing CNS therapies, marketed AZSTARYS (serdexmethylphenidate+dexmethylphenidate) for ADHD, and operates contract development and manufacturing services.

Founded 1999

Michigan, United States

251-500

Private

corium.com

Highlights

Focus Areas

Biopharma

Health Care

Medical

Pharmaceutical

Recent Investors

Financials

$235M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Corium.